Evidence map›Paper›PMID 23886820›Full record

ReviewClinical therapeutics2013

The bad taste of medicines: overview of basic research on bitter taste.

Julie A Mennella, Alan C Spector, Danielle R Reed, Susan E Coldwell

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Clinical therapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 115 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 2 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02923908 completednot on this mapstarted 2016, after this paper: background citation

A Pilot Study of Facial Recognition Software to Assess Palatability in Pediatric Patients

TypeobservationalSponsorArkansas Children's Hospital Research InstituteRan2016 to 2017Enrolled12ConditionsFacial ExpressionArmsNoldus Facereader 7, Voice Recording, 5-Point Facial Hedonic Scale, Follow-Up Questionnaire
NCT03627351 completednot on this mapstarted 2018, after this paper: background citation

Taste of Medicines for Children: Genetic Variation and Medical Adherence (Aim 1)

TypeobservationalSponsorMonell Chemical Senses CenterRan2018 to 2024Enrolled154ConditionsHealthy
3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 2 syntheses or guidelines pooled it, 286 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Julie A MennellaMonell Chemical Senses Center, Philadelphia, PA 19104-3308, USA. mennella@monell.org
Alan C Spector
Danielle R Reed
Susan E Coldwell
Monell Chemical Senses Center · USFlorida State University · USUniversity of Washington · US

Funding

Taste of medicines for children: genetic variation and medical adherenceR01DC011287 · NIDCD · MONELL CHEMICAL SENSES CENTER · PI LOWENTHAL, ELIZABETH DAWN, MENNELLA, JULIA ANNE · 2011 to 2022
$4.3M
MODEL FOR SENSITIVE PERIODS IN EARLY FLAVOR LEARNINGR01HD037119 · NICHD · MONELL CHEMICAL SENSES CENTER · PI MENNELLA, JULIA ANNE · 1999 to 2016
$3.9M
Molecular BiologyP30DC011735 · NIDCD · MONELL CHEMICAL SENSES CENTER · PI MOSINGER, BEDRICH · 2011 to 2015
$2.5M
NICHD NIH HHS R01 HD037119NIDCD NIH HHS P30 DC011735NIDCD NIH HHS P30DC011735NIDCD NIH HHS R01 DC011287NIDCD NIH HHS R01 DC01187
6 · The paper itself

Abstract

backgroundMany active pharmaceutical ingredients taste bitter and thus are aversive to children as well as many adults. Encapsulation of the medicine in pill or tablet form, an effective method for adults to avoid the unpleasant taste, is problematic for children. Many children cannot or will not swallow solid dose forms.

objectiveThis review highlights basic principles of gustatory function, with a special focus on the science of bitter taste, derived from studies of animal models and human psychophysics. We focus on the set of genes that encode the proteins that function as bitter receptors as well as the cascade of events that leads to multidimensional aspects of taste function, highlighting the role that animal models played in these discoveries. We also summarize psychophysical approaches to studying bitter taste in adult and pediatric populations, highlighting evidence of the similarities and differences in bitter taste perception and acceptance between adults and children and drawing on useful strategies from animal models.

resultsMedicine often tastes bitter, and because children are more bitter-sensitive than are adults, this creates problems with compliance. Bitter arises from stimulating receptors in taste receptor cells, with signals processed in the taste bud and relayed to the brain. However, there are many gaps in our understanding of how best to measure bitterness and how to ameliorate it, including whether it is more efficiently addressed at the level of receptor and sensory signaling, at the level of central processing, or by masking techniques. All methods of measuring responsiveness to bitter ligands-in animal models through human psychophysics or with "electronic tongues"-have limitations.

conclusionsBetter-tasting medications may enhance pediatric adherence to drug therapy. Sugars, acids, salt, and other substances reduce perceived bitterness of several pharmaceuticals, and although pleasant flavorings may help children consume some medicines, they often are not effective in suppressing bitter tastes. Further development of psychophysical tools for children will help us better understand their sensory worlds. Multiple testing strategies will help us refine methods to assess acceptance and compliance by various pediatric populations. Research involving animal models, in which the gustatory system can be more invasively manipulated, can elucidate mechanisms, ultimately providing potential targets. These approaches, combined with new technologies and guided by findings from clinical studies, will potentially lead to effective ways to enhance drug acceptance and compliance in pediatric populations.

Indexed as

Administration, OralAdultAnimalsChildChild, PreschoolFlavoring AgentsHumansInfantPerceptionReceptors, G-Protein-CoupledSucroseTabletsTasteTaste BudsTaste Receptors, Type 2Flavoring AgentsReceptors, G-Protein-CoupledSucroseTabletsTaste Receptors, Type 2animal modelsbitter tastechildrendrug complianceelectronic tonguespsychophysics

Identifiers

PMID23886820
PMCPMC3772669
OpenAlexW2081364727

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.